Trending Assets
Top investors this month
Trending Assets
Top investors this month
[Press Release] Shockwave Medical ($SWAV) and Genesis MedTech Obtain Regulatory Approval in China for Intravascular Lithotripsy
Shockwave received Japanese approval in March and now has received Chinese approval. Major news as they expand their footprint. The US share of their revenue has been increasing since 2019 when it was 53%, compared to 2021 which was 79%, and Q1'22 which was 84%. Obviously the demand in the US is ridiculously strong and the growth in Europe (the other major geographical segment they report) has been no slouch, but I'd love to see the need for report APAC. Hopefully Japan and China take off.


Post media


Shockwave Medical, Inc.
Shockwave Medical and Genesis MedTech Obtain Regulatory Approval in China for Intravascular Lithotripsy | Shockwave Medical, Inc.
Approvals Cover Both Coronary and Peripheral IVL Catheters and Generators Manufactured by Shockwave SANTA CLARA, Calif. and SINGAPORE , May 23, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely

Related
Already have an account?